Author:
Li Renzhong,Ruan Yunzhou,Sun Qiang,Wang Xiexiu,Chen Mingting,Zhang Hui,Zhao Yanlin,Zhao Jin,Chen Cheng,Xu Caihong,Su Wei,Pang Yu,Cheng Jun,Chi Junying,Wang Qian,Fu Yunting,Huan Shitong,Wang Lixia,Wang Yu,Chin Daniel P
Funder
Hong Wang (Bill & Melinda Gates Foundation)
Shenglan Tang (Duke University)
Christopher Fitzpatrick (WHO)
Reference41 articles.
1. Multidrug and extensively drug-resistant tuberculosis (M/XDR-TB): 2010 global report on surveillance and response. WHO/HTM/TB/2010.3,2010
2. Resolution WHA62.15. Prevention and control of multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis. Resolutions and decisions; annexes. 62nd World Health Assembly; Geneva, Switzerland; May 18–22, 2009. WHA62/2009/REC/1,2009
3. Agenda item 6.1. 134th session World Health Assembly Executive Board. Jan 21, 2014,2014
4. Universal access to care for multidrug-resistant tuberculosis: an analysis of surveillance data;Falzon;Lancet Infect Dis,2013
5. MDR tuberculosis—critical steps for prevention and control;Nathanson;N Engl J Med,2010